Author archive
May 20th, 2013 by Dr. Samuel Dyer
According to a Los Angeles Times investigation,...
Read morePosted in Pharma Industry Business News | No comments
May 20th, 2013 by Dr. Samuel Dyer
According to a Los Angeles Times investigation,...
Read morePosted in Pharma Industry Business News | No comments
May 20th, 2013 by Dr. Samuel Dyer
Forty-five women who had turned to Apotex for...
Read morePosted in Pharma Industry Business News | No comments
May 20th, 2013 by Dr. Samuel Dyer
Forty-five women who had turned to Apotex for...
Read morePosted in Pharma Industry Business News | No comments
May 20th, 2013 by Dr. Samuel Dyer
New price controls are on their way in India, and...
Read morePosted in Pharma Industry Business News | No comments
May 20th, 2013 by Dr. Samuel Dyer
New price controls are on their way in India, and...
Read morePosted in Pharma Industry Business News | No comments
May 20th, 2013 by Dr. Samuel Dyer
Joint ventures with Chinese companies have been...
Read morePosted in Pharma Industry Business News | No comments
May 20th, 2013 by Dr. Samuel Dyer
Joint ventures with Chinese companies have been...
Read morePosted in Pharma Industry Business News | No comments
May 20th, 2013 by Dr. Samuel Dyer
Actavis and Warner Chilcott have struck a deal....
Read morePosted in Pharma Industry Business News | No comments
May 20th, 2013 by Dr. Samuel Dyer
Actavis and Warner Chilcott have struck a deal....
Read morePosted in Pharma Industry Business News | No comments
May 20th, 2013 by Dr. Samuel Dyer
Call it a rite of spring. Every year about this...
Read morePosted in Pharma Industry Business News | No comments
May 20th, 2013 by Dr. Samuel Dyer
Call it a rite of spring. Every year about this...
Read morePosted in Pharma Industry Business News | No comments
May 19th, 2013 by Dr. Samuel Dyer
A new report suggests that improved health care...
Read morePosted in Breaking World Pharma News | No comments
May 19th, 2013 by Dr. Samuel Dyer
A new report suggests that improved health care...
Read morePosted in Breaking World Pharma News | No comments
May 17th, 2013 by Dr. Samuel Dyer
France drug regulator in January yanked...
Read morePosted in Pharma Industry Business News | No comments
May 17th, 2013 by Dr. Samuel Dyer
France drug regulator in January yanked...
Read morePosted in Pharma Industry Business News | No comments
May 17th, 2013 by Dr. Samuel Dyer
GlaxoSmithKline CFO Simon Dingemans?has found one...
Read morePosted in Pharma Industry Business News | No comments
May 17th, 2013 by Dr. Samuel Dyer
GlaxoSmithKline CFO Simon Dingemans?has found one...
Read morePosted in Pharma Industry Business News | No comments
May 16th, 2013 by Dr. Samuel Dyer
One in every 2 Americans has a buddy, a relative,...
Read morePosted in Drug Research | No comments
May 16th, 2013 by Dr. Samuel Dyer
One in every 2 Americans has a buddy, a relative,...
Read morePosted in Drug Research | No comments
May 15th, 2013 by Dr. Samuel Dyer
A clinical trial has shown that patients, and...
Read morePosted in Breaking World Pharma News | No comments
May 15th, 2013 by Dr. Samuel Dyer
How much is a generic drug worth to a payer? More...
Read morePosted in Pharma Industry Business News | No comments
May 15th, 2013 by Dr. Samuel Dyer
How much is a generic drug worth to a payer? More...
Read morePosted in Pharma Industry Business News | No comments
May 15th, 2013 by Dr. Samuel Dyer
Along with its partner, Astellas, Roche has won...
Read morePosted in Pharma Industry Business News | No comments
May 15th, 2013 by Dr. Samuel Dyer
Along with its partner, Astellas, Roche has won...
Read morePosted in Pharma Industry Business News | No comments
Older